We respond to SMC approval of Perjeta for early breast cancer prior to surgery on NHS in Scotland

Breast Cancer Now has welcomed the Scottish Medicines Consortium’s (SMC) decision to approve breast cancer drug Perjeta (pertuzumab) as a new...

10 December 2018

We respond to FDA approval of second drug for patients with BRCA-mutated breast cancer

Earlier this month, the US Food and Drug Administration (FDA) approved the use of a drug called talazoparib (Talzenna), to treat BRCA-mutated locally...

6 December 2018

Scottish breast screening "struggling to cope with demand"

Responding to a parliamentary question answered by Scottish Government, which reveals that there is a backlog in breast screening in some areas of...

5 December 2018

We respond to new report suggesting innovative cancer drugs are taking longer to reach NHS patients

NHS patients are waiting longer for new cancer drugs because of delays in taking them through clinical trials and getting them approved for use, a...

4 December 2018

We respond to research uncovering why women reject tamoxifen as preventive treatment for breast cancer

New research funded by Cancer Research UK has found that just a fifth of women at a higher risk of breast cancer think they need to take tamoxifen –...

3 December 2018

We respond to US trial suggesting women over 75 could benefit from regular breast screening

The trial analysed the results of 763,256 mammograms in the US – which detected a total of 3,944 breast cancer cases between 2007 and 2017. In the 75...

20 November 2018

Women often "left in the dark" about routine mammograms over 70

Discussing breast awareness and screening for women over 70 in the UK, Dr Emma Pennery, Clinical Director at Breast Cancer Care, says: “We...

20 November 2018

Our response to major review of cancer screening programmes as part of NHS Long Term Plan

Professor Sir Mike Richards will lead a major review of national cancer screening programmes as part of a “renewed drive to improve care and save...

15 November 2018

“Innovations are desperately needed to ensure that the screening programme is completely fail-safe"

Responding to the news that there will be a major overhaul of national screening programmes, including for breast cancer, Gunes Kalkan, Head of...

15 November 2018